Market Tracker

09/02 10:08am ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

7.03
Real-Time Quote
 +0.05 / +0.72%
Today’s Change
2.05
Today|||52-Week Range
8.25
+31.87%
Year-to-Date

Today’s Trading

Previous close6.98
Today’s open7.03
Day’s range6.91 - 7.04
Volume53,013
Average volume (3 months)1,514,105
Market cap$730.0M
Dividend yield--
Data as of 9:53am ET, 09/02/2014

Growth & Valuation

Earnings growth (last year)-5.32%
Earnings growth (this year)+22.98%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-2.32%
P/E ratioNM
Price/Sales11.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...0.000.00%
OREXOrexigen Therapeutic...+0.00+0.09%
RPTPRaptor Pharmaceutica...-0.21-1.91%
HZNPHorizon Pharma Inc+0.01+0.10%
Data as of 10:07am ET, 09/02/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$47.8M
Annual profit (last year)-$130.9M
Net profit margin-273.98%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert J. Mulroy
Senior Vice President-
Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts